Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation

scientific article published in March 2010

Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AMJCARD.2009.10.064
P698PubMed publication ID20211326

P50authorZhenyi XueQ114406231
Ron WaksmanQ7364511
Gilles LemesleQ56973448
Sara CollinsQ74423065
Lowell F SatlerQ88227547
Gabriel MaluendaQ88840517
Augusto D PichardQ106695449
Rebecca TorgusonQ106695518
Kenneth M KentQ106695575
William O SuddathQ106695580
Asmir I SyedQ114406228
I Itsik Ben-DorQ114406229
Kimberly KaneshigeQ114406230
P2093author name stringJoseph Lindsay
Cedric Delhaye
Kohei Wakabayashi
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)826-832
P577publication date2010-03-01
P1433published inAmerican Journal of CardiologyQ2208417
P1476titleLong-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation
P478volume105

Reverse relations

cites work (P2860)
Q43505647Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis
Q64082486Associations among circulating levels of follistatin-like 1, clinical parameters, and cardiovascular events in patients undergoing elective percutaneous coronary intervention with drug-eluting stents
Q36013281Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis
Q37259541Effects of low dose pioglitazone on restenosis and coronary atherosclerosis in diabetic patients undergoing drug eluting stent implantation
Q39680106Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention
Q34634358High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials
Q39240862Interleukin-6, but not C-reactive protein, predicts the occurrence of cardiovascular events after drug-eluting stent for unstable angina
Q57445651Lipoprotein(a), Interleukin-10, C-Reactive Protein, and 8-Year Outcome After Percutaneous Coronary Intervention
Q85776838Role of pre-procedural C-reactive protein level in the prediction of major adverse cardiac events in patients undergoing percutaneous coronary intervention: a meta-analysisof longitudinal studies
Q55428692Statin in the treatment of patients with myocardial infarction: A meta-analysis.
Q84535196Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting

Search more.